|
TBC1D23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.785000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.411600E-01 |
| Normal-vs-Stage2 |
6.009800E-01 |
| Normal-vs-Stage3 |
8.341800E-01 |
| Normal-vs-Stage4 |
2.264800E-01 |
| Stage1-vs-Stage2 |
3.929200E-01 |
| Stage1-vs-Stage3 |
8.744200E-01 |
| Stage1-vs-Stage4 |
3.896400E-01 |
| Stage2-vs-Stage3 |
5.543400E-01 |
| Stage2-vs-Stage4 |
2.039200E-01 |
| Stage3-vs-Stage4 |
3.703000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.192600E-01 |
| Normal-vs-AfricanAmerican |
9.038600E-01 |
| Normal-vs-Asian |
9.524200E-01 |
| Caucasian-vs-AfricanAmerican |
8.379800E-01 |
| Caucasian-vs-Asian |
9.311200E-01 |
| AfricanAmerican-vs-Asian |
9.903600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.793400E-01 |
| Normal-vs-Female |
6.619500E-02 |
| Male-vs-Female |
5.757000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.461200E-01 |
| Normal-vs-Extreme_Weight |
2.099400E-01 |
| Normal-vs-Obese |
9.556200E-01 |
| Normal-vs-Extreme_Obese |
8.301400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.737400E-01 |
| Normal_Weight-vs-Obese |
5.473400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.393000E-01 |
| Extreme_Weight-vs-Obese |
3.616400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.723000E-01 |
| Obese-vs-Extreme_Obese |
7.788800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.860100E-02 |
| Normal-vs-Age(41-60Yrs) |
6.064000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.089600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.892630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.792630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.557600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.683850E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.589600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.617160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.056000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.243600E-01 |
| Normal-VS-Type2 PRCC |
2.090100E-02 |
| Normal-VS-KIRP CIMP |
4.827600E-01 |
| Normal-VS-Unclassified PRCC |
4.619800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.238800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.236600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.940800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.342000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.576000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.083800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.207430E-01 |
| Normal-vs-N1 |
8.601000E-01 |
| Normal-vs-N2 |
1.174050E-02 |
| N0-vs-N1 |
2.263400E-01 |
| N0-vs-N2 |
3.551800E-01 |
| N1-vs-N2 |
1.236780E-01 |
|
|
